Male Breast Cancer (about 65 Cases and Literature Review)

Abstract

The male breast is a vestigial organ; it is rarely the site of malignant lesions. Male breast cancer accounts for only 1% of male cancers, and 1 to 2% of all breast cancers. The diagnostic is made later and the prognosis is worse than breast cancer in women. From January 1980 to December 2019,65 cases of male breast cancer have been recruited in the service of surgery of digestive cancer and liver transplantation AILE III of Ibn Rochd UHC in Casablanca. The frequency of male breast cancer was 0.5%; the average age was 60 years. The most common revelation mode was self-palpation of aretro areolar breast nodule in 84% of patients and the meantime onset was 27 months. The average size of the nodules was 5 cm. The treatment was surgical in 57 patients or 87.6% and was radical for 49 cases and for cleansing for 8 cases; 50 patients received radiation and chemotherapy and 12 patients received hormone therapy. The follow-up involved 39 patients with 11 cases of therapeutic failure and 20 cases of recurrence or metastasis. The overall survival at 2 years was 59% and 25% cases at 5 years. At the same stage, the treatment is the same for both genders. Our study aims to analyze the male breast cancer in his epidemiologic, clinical, pathological, therapeutic and prognostic aspects.